The changes to Medicare’s prescription drug cap were set in motion by the Biden administration’s 2022 Inflation Reduction Act ...

Medicare recipients will see a $2,000 out-of-pocket cap on some prescription drugs as part of several new provisions coming ...

The new price cap, part of the Inflation Reduction Act, will apply to all prescription drugs covered by Medicare.

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

The bipartisan agreement will fund the government through March. It could also reshape the pharmacy supply chain by reforming ...

Plus, a Philly judge has ordered a retrial of the $45 million malpractice verdict against Temple, and a Bucks County doctor ...

Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban’s Cost Plus Drugs and smaller, “transparent PBMs” have tried to wean pharmaceutical companies and health plans from ...

Discover how MultiCare Health System saved $1.12 million by partnering with Mark Cuban's Cost Plus Drug Co., allowing for reinvestment in new services and tech.

NPR's Ayesha Rascoe speaks with Forbes healthcare reporter Bruce Japsen about the legislative push to curb the power of pharmacy-benefit managers, who negotiate prices insurers pay for drugs.

Mark Cuban told Business Insider that AI's impact on a company's workforce will be determined by how well the firm can implement the technology.